Balance Sheet
Cash Flow Statement
AmortizationAmortizationAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in CashExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet Income
Growth Metrics
Income Statement
Others
Ratios

Avricore Health (AVCRF) Cash from Financing Activities (2017 - 2024)

Avricore Health has reported Cash from Financing Activities over the past 11 years, most recently at $12527.4 for Q4 2024.

  • Quarterly Cash from Financing Activities changed N/A to $12527.4 in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $41057.4 through Dec 2024, up 30.31% year-over-year, with the annual reading at $41340.6 for FY2024, 31.24% up from the prior year.
  • Cash from Financing Activities was $12527.4 for Q4 2024 at Avricore Health, down from $38485.3 in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $2.0 million in Q1 2021 and troughed at -$10686.4 in Q1 2024.
  • The 5-year median for Cash from Financing Activities is $28848.2 (2020), against an average of $226056.5.
  • Year-over-year, Cash from Financing Activities soared 29339.31% in 2021 and then tumbled 152.53% in 2024.
  • A 5-year view of Cash from Financing Activities shows it stood at $473420.0 in 2020, then plummeted by 87.11% to $61042.5 in 2021, then skyrocketed by 159.33% to $158302.7 in 2022, then tumbled by 92.95% to $11166.8 in 2023, then increased by 12.18% to $12527.4 in 2024.
  • Per Business Quant, the three most recent readings for AVCRF's Cash from Financing Activities are $12527.4 (Q4 2024), $38485.3 (Q3 2024), and $731.14 (Q2 2024).